Laboratoire de Recherche Résistance aux Antimicrobiens, Faculté de Médecine, Hôpital Charles Nicolle, Tunis, Tunisia.
Microb Drug Resist. 2013 Jun;19(3):231-6. doi: 10.1089/mdr.2012.0172. Epub 2013 Jan 30.
This study was conducted to investigate the molecular epidemiology of extended spectrum β-lactamase (ESBL)-producing Escherichia coli in community-acquired (urinary tract) infections (CA-UTI) in Tunisia. Between January 2007 and December 2009, 15 E. coli isolates were collected at the laboratory of microbiology of Charles Nicolle Hospital of Tunis. Microbial identification was done with conventional methods. Antibiotic susceptibility was determined by disk diffusion method and ESBL detection was done with double-disk synergy test. ESBL typing was performed by polymerase chain reaction (PCR) and sequencing. Phylogenetic groups, virulence factors, and sequence type (ST)131 were determined by PCR. Genetic relatedness between strains was examined by pulsed-field gel electrophoresis (PFGE) after restriction with XbaI. The prevalence of ESBL-producing E. coli in CA-UTI was 0.046%. The majority of isolates were multidrug resistant. ESBL types were CTX-M-15 (n=13) and SHV-12 (n=2). The most common phylogenetic group was B2 (n=11) and virulence score was greater than or equal to 9 in nine strains. PFGE revealed 12 clusters. The majority of isolates (n=14) belonged to ST131 clone and 11 of them were CTX-M producers. In conclusion, this is the first detailed documentation of CA-ESBLs producing E. coli in Tunisia. Of particular concern is the emergence in our community of the highly diffusing CTX-M-15-B2-ST131 E. coli clone, which requires strengthening surveillance measures to countervail this emergent public health problem.
本研究旨在调查突尼斯社区获得性(尿路感染)感染(CA-UTI)中产生超广谱β-内酰胺酶(ESBL)的大肠杆菌的分子流行病学。在 2007 年 1 月至 2009 年 12 月期间,在突尼斯 Charles Nicolle 医院的微生物学实验室收集了 15 株大肠杆菌分离株。微生物鉴定采用常规方法。药敏试验采用纸片扩散法,ESBL 检测采用双纸片协同试验。ESBL 型别通过聚合酶链反应(PCR)和测序进行。通过 PCR 确定了进化群、毒力因子和 ST131 型。通过 XbaI 限制的脉冲场凝胶电泳(PFGE)检测菌株间的遗传相关性。CA-UTI 中 ESBL 产大肠埃希菌的流行率为 0.046%。大多数分离株为多药耐药。ESBL 型别为 CTX-M-15(n=13)和 SHV-12(n=2)。最常见的进化群是 B2(n=11),9 株菌的毒力评分大于或等于 9。PFGE 显示 12 个聚类。大多数分离株(n=14)属于 ST131 克隆,其中 11 株为 CTX-M 产生菌。总之,这是突尼斯首例详细记录的 CA-ESBL 产大肠埃希菌。特别令人关注的是我们社区中高度扩散的 CTX-M-15-B2-ST131 大肠杆菌克隆的出现,这需要加强监测措施来应对这一新兴的公共卫生问题。